Complex oligosaccharides containing galactose

Complex oligosaccharides containing galactose are a broad class of glycan structures typically found on the surface of mammalian cells or as components of secreted glycoproteins. These oligosaccharides are synthesized in the Golgi apparatus through the action of galactosyltransferases, which add galactose residues to N-linked or O-linked glycan cores. Biologically, they play critical roles in cell-cell recognition, protein trafficking, and the modulation of immune responses by serving as ligands for endogenous lectins like Galectins and Siglecs. In a therapeutic context, these molecules are often discussed as ligands rather than targets themselves; however, specific galactose-containing glycans (such as the Thomsen-Friedenreich antigen) are targeted by monoclonal antibodies in oncology. Additionally, exogenous galacto-oligosaccharides (GOS) are utilized as prebiotics to stimulate the growth of beneficial gut microbiota, such as Bifidobacteria. In inflammatory conditions like idiopathic pulmonary fibrosis, the exposure of these oligosaccharides via the action of extracellular sialidases (e.g., NEU3) can prime neutrophils and exacerbate tissue damage, making the enzymes that modify these sugars a significant area of pharmacological interest.

Other names

Galactose-containing complex glycansGalactosylated N-glycansComplex-type oligosaccharidesGalacto-oligosaccharides (GOS)

These molecules typically serve as ligands for carbohydrate-binding proteins (lectins) such as Galectins or Selectins, or as substrates for enzymes like sialidases (e.g., NEU3) which remove terminal sialic acids to expose them. In the context of prebiotics like galacto-oligosaccharides, they act as metabolic substrates for beneficial gut bacteria.